As for distinguishing sporadic CJD from healthy controls, serum tau yielded a sensitivity of 91% and specificity of 83%, whereas serum NfL had 100% sensitivity and 100% specificity. This evidence concerns the gene NEFL and sporadic Creutzfeldt-Jakob disease.